For years, Congressman Jim Greenwood has pushed for legislation allowing for embryonic stem cell research, a controversial issue that pits biotech companies and scientists against conservatives and anti-abortion rights activists.Now, Greenwood may be joining the trade organization that endorsed his proposals, the Biotechnology Industry Organization.